These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11550817)

  • 1. Protein binding of glufosinate and factors affecting it revealed by an equilibrium dialysis technique.
    Hori Y; Koyama K; Fujisawa M; Nakajima M; Shimada K; Hirose Y; Kohda Y; Akuzawa H
    J Anal Toxicol; 2001 Sep; 25(6):439-42. PubMed ID: 11550817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the protein binding of YH-439 using an equilibrium dialysis technique. A new hepatoprotective agent.
    Lee WI; Yoon WH; Park JH; Lee JW; Shim CK; Lee MG
    Biopharm Drug Dispos; 1995 Dec; 16(9):775-89. PubMed ID: 8580401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glufosinate binds N-methyl-D-aspartate receptors and increases neuronal network activity in vitro.
    Lantz SR; Mack CM; Wallace K; Key EF; Shafer TJ; Casida JE
    Neurotoxicology; 2014 Dec; 45():38-47. PubMed ID: 25268653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique.
    Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2000 Oct; 21(7):285-91. PubMed ID: 11512128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the protein binding of bumetanide using an equilibrium dialysis technique.
    Shim HJ; Lee MG; Lee MH
    J Clin Pharm Ther; 1991 Dec; 16(6):467-76. PubMed ID: 1770075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative.
    Moon YJ; Kim SH; Ryu CK; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):167-77. PubMed ID: 11913709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the protein binding of azosemide using an equilibrium dialysis technique.
    Lee SH; Lee MG
    Biopharm Drug Dispos; 1995 Oct; 16(7):615-26. PubMed ID: 8785384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the protein binding of vancomycin.
    Shin WG; Lee MG; Lee MH; Kim ND
    Biopharm Drug Dispos; 1991 Dec; 12(9):637-46. PubMed ID: 1790309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological Factors Affecting Uptake and Translocation of Glufosinate.
    Takano HK; Beffa R; Preston C; Westra P; Dayan FE
    J Agric Food Chem; 2020 Mar; 68(10):3026-3032. PubMed ID: 32049526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis].
    Wiesner G; Taeger K; Peter K
    Anaesthesist; 1996 Apr; 45(4):323-9. PubMed ID: 8702049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood partition and protein binding of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
    Lee MH; Kim HJ; Kim SH; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
    Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):361-70. PubMed ID: 12889527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability, blood partition and plasma protein binding of ipriflavone, an isoflavone derivative.
    Kim SH; Lee JS; Lee MG
    Biopharm Drug Dispos; 1999 Oct; 20(7):355-60. PubMed ID: 10760844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability, blood partition, and protein binding of DA-5018, a new nonnarcotic analgesic.
    Shim HJ; Lee JJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):97-108. PubMed ID: 8824935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A toxicokinetic analysis in a patient with acute glufosinate poisoning.
    Hirose Y; Kobayashi M; Koyama K; Kohda Y; Tanaka T; Honda H; Hori Y; Yoshida K; Kikuchi M
    Hum Exp Toxicol; 1999 May; 18(5):305-8. PubMed ID: 10372751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glufosinate ammonium--some aspects of its mode of action in mammals.
    Hack R; Ebert E; Ehling G; Leist KH
    Food Chem Toxicol; 1994 May; 32(5):461-70. PubMed ID: 8206444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of toxicodynamic and toxicokinetic new approach methods into a weight-of-evidence analysis for pesticide developmental neurotoxicity assessment: A case-study with DL- and L-glufosinate.
    Dobreniecki S; Mendez E; Lowit A; Freudenrich TM; Wallace K; Carpenter A; Wetmore BA; Kreutz A; Korol-Bexell E; Friedman KP; Shafer TJ
    Regul Toxicol Pharmacol; 2022 Jun; 131():105167. PubMed ID: 35413399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the plasma protein binding of theophylline in health.
    Buss D; Leopold D; Smith AP; Routledge PA
    Br J Clin Pharmacol; 1983 Apr; 15(4):399-405. PubMed ID: 6849774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting the measurement of lidocaine protein binding by equilibrium dialysis in human serum.
    Ponganis KV; Stanski DR
    J Pharm Sci; 1985 Jan; 74(1):57-60. PubMed ID: 3981419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability, blood partition, and protein binding of NQ12, a new naphthoquinone derivative.
    Kim SH; Kim HJ; Ryu CK; Lee MG
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):165-72. PubMed ID: 10634309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.